NORPROLAC

This brand name is authorized in Austria, Australia, Canada, Cyprus, Spain, France, Hong Kong, Mexico, Netherlands, Poland, United Kingdom, South Africa

Active ingredients

The drug NORPROLAC contains one active pharmaceutical ingredient (API):

1 Quinagolide UNII 33474X943Y - QUINAGOLIDE HYDROCHLORIDE

Quinagolide is a selective dopamine D2-receptor agonist not belonging to the chemical classes of ergot or ergoline compounds. Owing to its dopaminergic action, the drug exerts a strong inhibitory effect on the secretion of the anterior pituitary hormone prolactin, but does not reduce normal levels of other pituitary hormones. Read about Quinagolide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NORPROLAC Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02CB04	Quinagolide	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8822H
Country: CA	Health Products and Food Branch	Identifier(s): 02223740, 02223759, 02223767, 02223775
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60631, 60632
Country: FR	Base de données publique des médicaments	Identifier(s): 64129342, 68713946, 69614207
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 41898, 41903
Country: HK	Department of Health Drug Office	Identifier(s): 38461, 54167, 54168
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 343M94
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 37559, 37567
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100048297, 100048305, 100048334, 100384109
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/21.12/0528, 28/21.12/0529, 28/21.12/0530, 28/21.12/0531